Loading...

Eckert & Ziegler Strahlen- und Medizintechnik AG

0NZY.LLSE
Healthcare
Medical - Pharmaceuticals
£39.74
£0.01(0.03%)

Eckert & Ziegler Strahlen- und Medizintechnik AG (0NZY.L) Company Profile & Overview

Explore Eckert & Ziegler Strahlen- und Medizintechnik AG’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Eckert & Ziegler Strahlen- und Medizintechnik AG (0NZY.L) Company Profile & Overview

Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, hot cells, and services for radiopharmaceuticals, as well as eye applicators and prostate implants. The Isotope Products segment manufactures and sells radiation sources for imaging, measurement technology, material analysis, quality assurance, and environmental monitoring. This segment also offers calibration sources for medical imaging systems, and homeland security and radiometric level measurement products. The company was founded in 1992 and is headquartered in Berlin, Germany.

SectorHealthcare
IndustryMedical - Pharmaceuticals
CEOHarald Hasselmann

Contact Information

49 30 94 10 84 0
Robert-Rössle-Strasse 10, Berlin, 13125

Company Facts

1,085 Employees
IPO DateJul 20, 2009
CountryDE

Frequently Asked Questions

;